# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001171843-18-001855
Filing Date
2018-03-12
Accepted
2018-03-12 14:51:31
Documents
77
Period of Report
2017-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | f10k_022718p.htm | 10-K | 1142613
2 | EXHIBIT 10.88 | exh_1088.htm | EX-10.88 | 256938
3 | EXHIBIT 21 | exh_21.htm | EX-21 | 2476
4 | EXHIBIT 23 | exh_23.htm | EX-23 | 10788
5 | EXHIBIT 31.1 | exh_311.htm | EX-31.1 | 7036
6 | EXHIBIT 31.2 | exh_312.htm | EX-31.2 | 7050
7 | EXHIBIT 32.1 | exh_321.htm | EX-32.1 | 4010
8 | EXHIBIT 32.2 | exh_322.htm | EX-32.2 | 4139
15 | GRAPHIC | graph_1.jpg | GRAPHIC | 38558
16 | GRAPHIC | exh1088_01.jpg | GRAPHIC | 297929
| Complete submission text file | 0001171843-18-001855.txt |  | 7113743

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL INSTANCE FILE | bcrx-20171231.xml | EX-101.INS | 1175482
10 | XBRL SCHEMA FILE | bcrx-20171231.xsd | EX-101.SCH | 74613
11 | XBRL CALCULATION FILE | bcrx-20171231_cal.xml | EX-101.CAL | 57454
12 | XBRL DEFINITION FILE | bcrx-20171231_def.xml | EX-101.DEF | 534025
13 | XBRL LABEL FILE | bcrx-20171231_lab.xml | EX-101.LAB | 472760
14 | XBRL PRESENTATION FILE | bcrx-20171231_pre.xml | EX-101.PRE | 551624

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23186 | Film No.: 18683093
SIC: 2836 Biological Products, (No Diagnostic Substances)